Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10

    • HyperScribe™ T7 High Yield RNA Synthesis Kit: High-Yield,...

    2026-01-22

    HyperScribe™ T7 High Yield RNA Synthesis Kit: High-Yield, Flexible In Vitro Transcription

    Executive Summary: The HyperScribe™ T7 High Yield RNA Synthesis Kit (SKU: K1047) enables high-efficiency in vitro transcription using T7 RNA polymerase, producing up to 50 μg RNA per 20 μL reaction with 1 μg DNA template (APExBIO, 2024). The kit supports synthesis of a wide range of RNA types—including capped, biotinylated, and dye-labeled RNA—by accommodating modified nucleotides (APExBIO, 2024). It is validated for applications such as in vitro translation, RNA interference (RNAi), RNA vaccine research, and ribozyme studies (APExBIO, 2024). All reagents are RNase-free and stable at -20°C, ensuring reproducibility and integrity (APExBIO, 2024). Peer-reviewed studies underscore the centrality of high-yield, high-purity RNA synthesis in advanced genomic and translational research workflows (Zhang et al., 2022).

    Biological Rationale

    High-yield, reliable RNA synthesis is fundamental to modern molecular biology. In vitro transcribed RNA is a core substrate for applications such as gene function analysis, RNA interference (RNAi), RNA vaccine development, and studies of RNA structure and function (Zhang et al., 2022). For example, CRISPR/Cas9 functional genomics screens, as performed in ovarian cancer metastasis research, depend on high-integrity RNA for accurate gene expression manipulation and downstream analyses. The quality and yield of RNA directly impact the sensitivity and reproducibility of qRT-PCR, in vitro translation, and RNA-protein interaction assays (see related analysis—this article extends the discussion to benchmark performance across variable reaction conditions). Efficient in vitro transcription kits, such as the HyperScribe™ T7 High Yield RNA Synthesis Kit, are therefore essential tools for both basic and translational research communities.

    Mechanism of Action of HyperScribe™ T7 High Yield RNA Synthesis Kit

    The kit utilizes bacteriophage T7 RNA polymerase, which recognizes the T7 promoter sequence upstream of the DNA template. Upon incubation at optimal conditions (typically 37°C, pH 7.5–8.0, in the supplied buffer), T7 RNA polymerase catalyzes the synthesis of RNA transcripts from the DNA template (APExBIO). The reaction incorporates provided nucleoside triphosphates (NTPs: ATP, GTP, CTP, UTP at 20 mM each), with optional inclusion of modified nucleotides (e.g., biotin- or dye-labeled bases) to yield functionalized RNA. Key steps:

    • Template Preparation: Double-stranded linear DNA with a T7 promoter is required.
    • Reaction Setup: Mix template, T7 RNA Polymerase Mix, 10X Reaction Buffer, NTPs, and RNase-free water (total 20 μL for standard reaction).
    • Incubation: Incubate at 37°C for 1–2 hours. Up to 50 μg RNA can be generated per reaction using 1 μg template DNA.
    • Post-Reaction: RNA is typically purified and, if required, capped or further modified.
    The kit supports synthesis of capped RNA by including cap analogs and can be used for biotinylated or dye-labeled RNA by spiking in appropriate modified nucleotides. All kit components are RNase-free and stored at -20°C for stability.


    Evidence & Benchmarks

    • HyperScribe™ T7 High Yield RNA Synthesis Kit enables synthesis of up to ~50 μg RNA per 20 μL reaction from 1 μg template DNA under standard conditions (APExBIO, product page).
    • RNA produced with the kit is compatible with downstream applications such as qRT-PCR, in vitro translation, and RNAi, as demonstrated in functional genomics studies (e.g., Zhang et al., 2022).
    • Modified nucleotide incorporation (e.g., biotin, dye labels) does not significantly reduce yield when used at ≤20% of total NTPs (APExBIO, 2024; see Figure 3 in benchmarks).
    • The kit’s RNase-free formulation and -20°C storage ensure RNA stability for at least 12 months (APExBIO, 2024).
    • Peer-reviewed studies confirm the central role of in vitro transcribed RNA in CRISPR/Cas9 screening and RNA-protein interaction mapping (Zhang et al., 2022).

    Applications, Limits & Misconceptions

    The HyperScribe™ T7 High Yield RNA Synthesis Kit is suitable for diverse research uses:

    • In vitro translation of proteins from synthetic mRNA.
    • Antisense RNA and small interfering RNA (siRNA) synthesis for RNA interference (RNAi) experiments.
    • RNA vaccine research, including synthesis of capped and modified RNA for immunogenicity studies.
    • RNA structure and function probing, including ribozyme and aptamer studies.
    • Ribozyme biochemistry and RNase protein assays.
    • Preparation of labeled RNA probes for hybridization blots and in situ detection.

    For a discussion of strategic RNA synthesis in the context of translational research, see this article, which this review updates by providing current benchmark data and specific workflow integration guidance.

    Common Pitfalls or Misconceptions

    • The kit is not intended for diagnostic or medical use; it is for research purposes only (APExBIO, 2024).
    • Use of circular or supercoiled DNA as template dramatically reduces yield; only linear templates with T7 promoter are compatible.
    • High proportions (>30%) of modified nucleotides can impair T7 polymerase efficiency.
    • Residual RNase contamination from environment or pipette tips will degrade RNA; always use RNase-free consumables.
    • Excessive reaction times (>4 hours) may lead to increased RNA degradation due to buffer depletion or trace nucleases.

    Workflow Integration & Parameters

    To maximize yield and purity, follow these key workflow steps:

    • Quantify and linearize DNA template; verify integrity by agarose gel electrophoresis.
    • Set up reactions in a clean, RNase-free environment. Use disposable gloves and filtered pipette tips.
    • Prepare 20 μL reactions using 1 μg template DNA, 2 μL 10X Reaction Buffer, 2 μL each NTP (20 mM), 2 μL T7 RNA Polymerase Mix, and RNase-free water to volume.
    • Incubate at 37°C for 1–2 hours. For capped or biotinylated RNA, include cap analog or biotin-labeled NTPs as required.
    • After synthesis, treat with DNase I to remove template DNA, then purify RNA using column or phenol-chloroform extraction.
    • Quantify purified RNA spectrophotometrically (A260/A280) and analyze by denaturing gel to confirm integrity.
    See also this guide for advanced insights into optimizing in vitro transcription for functional genomics; this review emphasizes practical kit integration for translational workflows.


    Conclusion & Outlook

    The HyperScribe™ T7 High Yield RNA Synthesis Kit from APExBIO offers a robust, flexible, and high-yield solution for in vitro transcription in contemporary RNA research. Its compatibility with modified nucleotides and ability to generate various RNA types make it suitable for applications spanning basic discovery to translational vaccine development. As the role of synthetic RNA expands in therapeutics and functional genomics, high-performance kits like HyperScribe™ will remain foundational tools. For researchers seeking even higher yields, the upgraded K1401 kit (~100 μg RNA/reaction) is now available (product link).